August 15, 2005 12:00 ET

Curis, Inc. [CRIS] CEO to Ring The NASDAQ Stock Market Closing Bell

Company Celebrates Anniversary

-- (MARKET WIRE) -- August 15, 2005 --


Daniel Passeri, CEO of Curis, Inc. (NASDAQ: CRIS), will preside over the closing bell to celebrate its 5-year anniversary on the NASDAQ. Curis, Inc. is a therapeutic drug development company focusing on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer (under partnership with Genentech, which also includes a co-development collaboration between Curis and Genentech for a basal cell carcinoma product candidate), kidney disease (licensed to Ortho Biotech, a subsidiary of Johnson & Johnson), neurological disorders (partnered with Wyeth Pharmaceuticals), hair growth, and cardiovascular disease.


NASDAQ MarketSite -- 4 Times Square -- 43rd & Broadway -- Broadcast Studio


Tuesday, August 16th, at 4:00 p.m. EDT

Feed Information:

The closing bell is available from 3:50 p.m. to 4:05 p.m. on uplink IA-6 C-band/transponder 17. The downlink frequency is 4040 Vertical; Audio 6.2-6.8 The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220.


To obtain a hi-resolution photograph of the Market Close, please go to and click on the market close of your choice.

Contact Information

  • Contacts:
    Megan Burling
    Investor Relations
    (617) 503-6658
    Email Contact

    NASDAQ MarketSite:
    Stephanie Lowenthal